CVE-2026-21980

Katalog CVE

CVSS 6.5 · Medium EPSS 0,21%

Kerentanan pada oracle life sciences central coding. Skor CVSS 3.1 6.5 (Medium) menurut oracle.com.

Deskripsi (NVD)

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Rincian

Terbit di NVD

20 Januari 2026

Terakhir diubah

17 Juni 2026

Status NVD

Analyzed

CVSS 3.1

6.5 (Medium), sumber oracle.com
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N · uraikan di kalkulator

EPSS (30 hari)

0,21% peluang dieksploitasi; lebih tinggi dari 10,7% CVE lain

Produk dan versi terdampak

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

• https://www.oracle.com/security-alerts/cpujan2026.html advisory vendor